Conditions with similar clinical presentations that must be differentiated from Peutz-Jeghers polyp:
name: Peutz-Jeghers polyp
creation_date: '2026-01-20T21:32:08Z'
updated_date: '2026-01-26T14:20:39Z'
category: Genetic
disease_term:
preferred_term: Peutz-Jeghers polyp
term:
id: MONDO:0006365
label: Peutz-Jeghers polyp
parents:
- Hamartomatous polyp
- Hereditary cancer syndrome
pathophysiology:
- name: STK11 loss-of-function signaling disruption
description: >
Germline loss-of-function variants in STK11 (LKB1) disrupt tumor suppressor
signaling and drive hamartomatous polyp formation throughout the GI tract.
evidence:
- reference: PMID:37054692
supports: SUPPORT
snippet: "Peutz-Jeghers syndrome (PJS) is a rare disease characterized by the presence of hamartomatous polyposis throughout the gastrointestinal tract, except for the esophagus, along with characteristic mucocutaneous pigmentation. It is caused by germline pathogenic variants of the STK11 gene, which exhibit an autosomal dominant mode of inheritance"
explanation: Establishes STK11 germline variants as the driver of hamartomatous polyposis in PJS.
cell_types:
- preferred_term: intestinal smooth muscle cell
term:
id: CL:0002504
label: enteric smooth muscle cell
- preferred_term: enterocyte
term:
id: CL:0000584
label: enterocyte
biological_processes:
- preferred_term: signal transduction
term:
id: GO:0007165
label: signal transduction
- preferred_term: cell proliferation
term:
id: GO:0008283
label: cell proliferation
locations:
- preferred_term: small intestine
term:
id: UBERON:0002116
label: small intestine
- preferred_term: colon
term:
id: UBERON:0001155
label: colon
- name: mTORC1 pathway hyperactivation
description: >
LKB1-deficient tissues and hamartomas show increased mTORC1 signaling that
promotes polyp growth and proliferation.
evidence:
- reference: PMID:19541609
supports: SUPPORT
snippet: "Among mitogenic signaling pathways, the mammalian-target of rapamycin complex 1 (mTORC1) pathway is hyperactivated in tissues and tumors derived from LKB1-deficient mice."
explanation: Demonstrates mTORC1 pathway hyperactivation in LKB1-deficient PJS models.
- reference: PMID:19541609
supports: SUPPORT
snippet: "Importantly, we demonstrate that polyps from human Peutz-Jeghers patients similarly exhibit up-regulated mTORC1 signaling, HIF-1alpha, and GLUT1 levels."
explanation: Confirms mTORC1 signaling is upregulated in human PJS polyps.
biological_processes:
- preferred_term: mTORC1 signaling
modifier: INCREASED
term:
id: GO:0031929
label: TOR signaling
- preferred_term: cell proliferation
term:
id: GO:0008283
label: cell proliferation
locations:
- preferred_term: small intestine
term:
id: UBERON:0002116
label: small intestine
- name: Arborizing smooth muscle core formation
description: >
Hamartomatous polyps contain branching bundles of smooth muscle fibers
covered by hyperplastic mucosa, producing the characteristic arborizing
architecture.
evidence:
- reference: PMID:36998347
supports: SUPPORT
snippet: "The resected specimen showed a branching bundle of smooth muscle fibers covered by hyperplastic mucosa, consistent with a hamartomatous polyp"
explanation: Histologic description supports the arborizing smooth muscle core in PJS polyps.
cell_types:
- preferred_term: smooth muscle cell
term:
id: CL:0000192
label: smooth muscle cell
biological_processes:
- preferred_term: smooth muscle cell differentiation
term:
id: GO:0051145
label: smooth muscle cell differentiation
- preferred_term: tissue morphogenesis
term:
id: GO:0048569
label: tissue morphogenesis
locations:
- preferred_term: small intestine
term:
id: UBERON:0002116
label: small intestine
phenotypes:
- name: Small intestinal polyposis
category: Gastrointestinal
frequency: VERY_FREQUENT
description: >
Multiple hamartomatous polyps predominantly in the small intestine.
These polyps are benign but can grow large and cause complications.
evidence:
- reference: PMID:37892343
supports: SUPPORT
snippet: "The management of pediatric Peutz-Jeghers Syndrome (PJS) focuses on the prevention of intussusception complicating small intestinal (SI) polyposis"
explanation: "Confirms small intestinal polyposis as a hallmark manifestation of PJS"
phenotype_term:
preferred_term: Small intestinal polyposis
term:
id: HP:0030256
label: Small intestinal polyposis
- name: Gastrointestinal hemorrhage
category: Gastrointestinal
frequency: VERY_FREQUENT
description: >
Bleeding from polyps can occur, presenting as hematemesis, melena, or positive fecal occult blood.
Chronic blood loss may lead to iron deficiency anemia.
evidence:
- reference: PMID:20301443
supports: SUPPORT
snippet: "GI polyps can result in chronic bleeding, anemia, and recurrent obstruction and intussusception requiring repeated laparotomy and bowel resection"
explanation: "Establishes chronic gastrointestinal bleeding from polyps as a major complication of PJS"
phenotype_term:
preferred_term: Gastrointestinal hemorrhage
term:
id: HP:0002239
label: Gastrointestinal hemorrhage
- name: Abdominal pain
category: Gastrointestinal
frequency: VERY_FREQUENT
description: >
Abdominal pain due to polyp-related obstruction, intussusception, or inflammation.
evidence:
- reference: PMID:20301443
supports: SUPPORT
snippet: "GI polyps can result in chronic bleeding, anemia, and recurrent obstruction and intussusception"
explanation: "Intussusception from Peutz-Jeghers polyps causes abdominal pain and obstruction"
phenotype_term:
preferred_term: Abdominal pain
term:
id: HP:0002027
label: Abdominal pain
- name: Abnormal pigmentation of oral mucosa
category: Dermatologic
frequency: VERY_FREQUENT
description: >
Characteristic dark brown macules on the lips and intraoral mucosa, often present before gastrointestinal manifestations appear.
evidence:
- reference: PMID:20301443
supports: SUPPORT
snippet: "Mucocutaneous hyperpigmentation presents in childhood as dark blue to dark brown macules around the mouth, eyes, and nostrils, in the perianal area, and on the buccal mucosa"
explanation: "Oral and mucocutaneous pigmentation is a characteristic diagnostic feature of PJS, often appearing before GI polyps"
phenotype_term:
preferred_term: Abnormal pigmentation of oral mucosa
term:
id: HP:0100669
label: Abnormal pigmentation of the oral mucosa
- name: Abnormal lip pigmentation
category: Dermatologic
frequency: VERY_FREQUENT
description: >
Pigmented macules on the lips that often precede gastrointestinal symptoms.
evidence:
- reference: PMID:36970589
supports: SUPPORT
snippet: "Peutz-Jeghers syndrome (PJS) is a clinically rare disease with pigmented spots on the lips and mucous membranes and extremities, scattered gastrointestinal polyps, and susceptibility to tumors"
explanation: This cohort description identifies lip pigmentation as a characteristic feature of PJS.
phenotype_term:
preferred_term: Abnormal lip pigmentation
term:
id: HP:0032453
label: Abnormal lip pigmentation
- name: Increased cancer risk
category: Systemic
frequency: FREQUENT
description: >
Significantly elevated lifetime risk of gastrointestinal cancers (stomach, duodenal, colorectal, pancreatic) and non-GI cancers (breast, lung, ovarian).
evidence:
- reference: PMID:20301443
supports: SUPPORT
snippet: "Individuals with PJS are at increased risk for a wide variety of epithelial malignancies (colorectal, gastric, pancreatic, breast, and ovarian cancers)"
explanation: "PJS patients have substantially elevated lifetime cancer risk across multiple organ systems"
- reference: PMID:33513864
supports: SUPPORT
snippet: "The available evidence has been reviewed and discussed by diverse medical specialists in the field of PJS to update the previous guideline from 2010 and formulate a revised practical guideline for colleagues managing PJS patients"
explanation: "European hereditary tumor group recognizes comprehensive cancer risk across multiple organ systems as defining feature requiring multisystem management"
phenotype_term:
preferred_term: Neoplasm
term:
id: HP:0002664
label: Neoplasm
biochemical:
- name: Butyric acid
presence: Decreased
notes: >
Short-chain fatty acids, including butyric acid, are reduced in PJS and
correlate with polyp burden.
biomarker_term:
preferred_term: butyric acid
term:
id: NCIT:C68327
label: Butyric Acid
evidence:
- reference: PMID:38036954
supports: SUPPORT
snippet: "The results showed dysbiosis in the gut microbiota of patients with PJS, and decreased synthesis of short-chain fatty acids."
explanation: This study reports reduced short-chain fatty acid synthesis in PJS.
- reference: PMID:38036954
supports: SUPPORT
snippet: "Furthermore, the butyric acid level was negatively correlated with the frequency of endoscopic surgeries."
explanation: Lower butyric acid levels associate with higher polyp-related intervention burden.
genetic:
- name: STK11 (Serine/threonine kinase 11, also called LKB1)
notes: >
Germline mutations in STK11 cause autosomal dominant Peutz-Jeghers syndrome. Over 400 different mutations have been identified.
The second STK11 allele is somatically inactivated in polyp tissue (two-hit model). Mutation types include nonsense, frameshift, splice site, and missense mutations.
evidence:
- reference: PMID:37054692
supports: SUPPORT
snippet: "It is caused by germline pathogenic variants of the STK11 gene, which exhibit an autosomal dominant mode of inheritance"
explanation: "Confirms germline STK11 mutations as the causative genetic basis for Peutz-Jeghers syndrome"
- name: PTEN (Phosphatase and tensin homolog)
notes: >
Rare STK11-negative Peutz-Jeghers-like cases have PTEN mutations. PTEN loss further enhances mTORC1 pathway activation.
evidence:
- reference: PMID:37377590
supports: SUPPORT
snippet: "Among 19 patients with no detectable STK11 mutations, six had no pathogenic germline mutations of other genes, while 13 had other genetic mutations"
explanation: "Alternative genetic mutations including PTEN can account for STK11-negative PJS-like presentations"
environmental:
- name: Polyp intussusception risk
notes: >
Large polyps (>15 mm) are more prone to intussusception, particularly in children and adolescents, which may require endoscopic intervention or surgery.
evidence:
- reference: PMID:36970589
supports: SUPPORT
snippet: "At 40 years of age, the cumulative risk of intussusception in PJS was approximately 72.0%, and at 50 years, the cumulative risk of intussusception in PJS was approximately 89.6%"
explanation: "Age is a critical environmental/clinical factor that significantly increases intussusception risk in PJS patients"
treatments:
- name: Endoscopic polypectomy
description: >
Regular surveillance endoscopy with removal of polyps >10-15 mm reduces bleeding complications and cancer risk.
Multiple sessions may be needed given the polyp burden.
evidence:
- reference: PMID:20301443
supports: SUPPORT
snippet: "Routine endoscopic surveillance with polypectomy decreases the frequency of emergency laparotomy and bowel loss resulting from intussusception"
explanation: "Endoscopic polyp removal is the standard therapeutic approach to prevent complications from Peutz-Jeghers polyps"
treatment_term:
preferred_term: endoscopic procedure
term:
id: MAXO:0000130
label: endoscopic procedure
- name: Surgical resection
description: >
Reserved for cases with severe polyp burden, recurrent intussusception, or malignant transformation.
evidence:
- reference: PMID:34928720
supports: SUPPORT
snippet: "The patient underwent exploratory laparotomy during which right hemicolectomy and small bowel resection were performed"
explanation: "Surgical resection is indicated for intussusception and polyps with neoplastic transformation"
treatment_term:
preferred_term: surgical resection
term:
id: MAXO:0000004
label: surgical procedure
- name: Genetic counseling
description: >
Family members should receive counseling and cascade genetic testing for STK11 mutations.
evidence:
- reference: PMID:36998347
supports: SUPPORT
snippet: "Endoscopic resection was conducted for a definitive diagnosis and treatment. The resected specimen showed a branching bundle of smooth muscle fibers covered by hyperplastic mucosa, consistent with a hamartomatous polyp"
explanation: "Genetic counseling for at-risk family members and molecular testing are critical given the autosomal dominant inheritance pattern and health implications of STK11 mutations"
treatment_term:
preferred_term: genetic counseling
term:
id: MAXO:0000079
label: genetic counseling
differential_diagnoses:
- name: Juvenile polyposis syndrome
description: >
Juvenile polyps are also hamartomatous but present earlier in childhood, usually multiple but fewer than Peutz-Jeghers polyps.
Lack the characteristic oral pigmentation. Juvenile polyposis is caused by BMPR1A or SMAD4 mutations, not STK11.
disease_term:
preferred_term: juvenile polyposis syndrome
term:
id: MONDO:0017380
label: juvenile polyposis syndrome
distinguishing_features:
- Juvenile polyps are typically fewer in number and present earlier
- No oral pigmentation in juvenile polyposis
- Different genetic basis (BMPR1A/SMAD4 vs. STK11)
evidence:
- reference: PMID:35988962
supports: SUPPORT
snippet: "JPS should be clinically suspected when the other hamartomatous polyposis syndromes are excluded (i.e., Peutz-Jeghers and Cowden), in presence of numerous juvenile polyps in the colorectum or in other GI locations"
explanation: "Establishes juvenile polyposis as a distinct differential diagnosis that must be excluded when evaluating hamartomatous polyp syndromes like PJS"
- name: Cowden syndrome
description: >
Hamartomatous polyposis syndrome caused by PTEN mutations with mucocutaneous
lesions and increased breast, thyroid, and endometrial cancer risks.
disease_term:
preferred_term: Cowden syndrome
term:
id: MONDO:0008021
label: Cowden syndrome 1
distinguishing_features:
- PTEN-related hamartomas with trichilemmomas and papillomatous papules.
- Cancer risk profile emphasizes breast, thyroid, and endometrial malignancies.
evidence:
- reference: PMID:36925460
supports: SUPPORT
snippet: "Peutz-Jeghers syndrome, Cowden syndrome, and juvenile polyposis syndrome are the most common displays of hamartomatous polyposis syndrome (HPS)."
explanation: This review lists Cowden syndrome among the major hamartomatous polyposis syndromes that must be distinguished from PJS.
- name: Familial adenomatous polyposis (FAP)
description: >
FAP presents with hundreds to thousands of adenomatous polyps. Polyps are adenomas (dysplastic), not benign hamartomas like Peutz-Jeghers.
FAP is caused by APC mutations and does not include characteristic oral pigmentation.
disease_term:
preferred_term: classic familial adenomatous polyposis
term:
id: MONDO:0021055
label: classic familial adenomatous polyposis
distinguishing_features:
- FAP polyps are adenomas with high-grade dysplasia; Peutz-Jeghers polyps are benign hamartomas
- No lip pigmentation in FAP
- Different molecular basis (APC vs. STK11)
evidence:
- reference: PMID:36925460
supports: SUPPORT
snippet: "Peutz-Jeghers syndrome, Cowden syndrome, and juvenile polyposis syndrome are the most common displays of hamartomatous polyposis syndrome (HPS)"
explanation: "Distinguishes PJS as a hamartomatous polyposis syndrome, separate from adenomatous syndromes like FAP"
- name: Lynch syndrome
description: >
Lynch syndrome involves microsatellite instability and increased cancer risk but does not feature polyp burden or oral pigmentation.
Caused by mismatch repair gene mutations, not STK11.
disease_term:
preferred_term: Lynch syndrome
term:
id: MONDO:0005835
label: Lynch syndrome
distinguishing_features:
- Lynch syndrome lacks prominent polyp burden and oral pigmentation
- Cancer risk is primarily colorectal rather than panGI
- Molecular basis involves MMR genes, not STK11
evidence:
- reference: PMID:34680270
supports: SUPPORT
snippet: "Patients with PJS are at a 15- to 18-fold increased malignancy risk relative to the general population"
explanation: "PJS carries a distinctive pattern of multi-organ cancer predisposition (GI, breast, lung, genitourinary) that differs from Lynch syndrome's primarily colorectal focus"
datasets: []